Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER_GOV × Standard of Care × Thoracic × Clear all

Phase

Status

Sponsor Class

OTHER 39 INDUSTRY 5 OTHER_GOV 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 3 Breast 3 Tumor-Agnostic 1 Thoracic 1 Other 1 Gynecologic 1 Genitourinary 1

Conditions

Pulmonary Disease, Chronic Obstructive 1 Lung Neoplasms 1

Interventions

Cisplatin 12 Carboplatin 11 Pemetrexed 10 Drug Therapy 9 Gemcitabine 7 Docetaxel 7 Gefitinib 6 camrelizumab 5 Radiotherapy 5 Paclitaxel 5 Irinotecan 5 Erlotinib Hydrochloride 5 tislelizumab 4 apatinib 4 Nivolumab 4 Bevacizumab 4 Simvastatin 3 Platinum Compounds 3 Etoposide 3 Endostatins 3 toripalimab 2 surufatinib 2 pembrolizumab 2 olaparib 2 endostar protein 2 anlotinib 2 Topotecan 2 Thalidomide 2 Surgical Procedures, Operative 2 S 1 (combination) 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02405273 2025-06-11

PUREAIR

Azienda USL Reggio Emilia - IRCCS

Phase NA Completed

Lung Neoplasms, Pulmonary Disease, Chronic Obstructive

Data powered by HemOnc (CC BY 4.0) Colophon ⚡